These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 6184148)

  • 21. Heterogeneity of methotrexate binding in human colon tumor cells.
    Iqbal MP; Mehboobali N; Waqar MA; Ahmed M
    J Pak Med Assoc; 1991 Jun; 41(6):136-9. PubMed ID: 1895499
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A fluorescent analogue of methotrexate as a probe for folate antagonist molecular receptors.
    Susten SS; Kempton RJ; Black AM; Freisheim JH
    Biochem Pharmacol; 1984 Jun; 33(12):1957-62. PubMed ID: 6732854
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Antibody to dihydrofolate reductase from a methotrexate-resistant subline of the L1210 lymphoma.
    Perkins JP; Hillman G; Fischer D; Bertino JR
    Mol Pharmacol; 1969 May; 5(3):213-8. PubMed ID: 4389029
    [No Abstract]   [Full Text] [Related]  

  • 24. Polymorphism of dihydrofolate reductase from a methotrexate-resistant subline of L1210 cells.
    Duffy TH; Beckman SB; Sato JK; Nagae H; Vitols KS; Huennekens FM
    Adv Enzyme Regul; 1985; 23():3-12. PubMed ID: 4072799
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Role of the cellular oxidation-reduction state in methotrexate binding to dihydrofolate reductase and dissociation induced by reduced folates.
    Matherly LH; Anderson LA; Goldman ID
    Cancer Res; 1984 Jun; 44(6):2325-30. PubMed ID: 6609765
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Isolation of multiple forms of dihydrofolate reductase from mouse liver.
    Soucek J; Ziźkovský V; Foŕt P
    Acta Univ Carol Med Monogr; 1977; (79 Pt 3):193-200. PubMed ID: 97936
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The mechanism of transport of the multitargeted antifolate (MTA) and its cross-resistance pattern in cells with markedly impaired transport of methotrexate.
    Zhao R; Babani S; Gao F; Liu L; Goldman ID
    Clin Cancer Res; 2000 Sep; 6(9):3687-95. PubMed ID: 10999762
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Structures of dihydrofolate reductase-thymidylate synthase of Trypanosoma cruzi in the folate-free state and in complex with two antifolate drugs, trimetrexate and methotrexate.
    Senkovich O; Schormann N; Chattopadhyay D
    Acta Crystallogr D Biol Crystallogr; 2009 Jul; 65(Pt 7):704-16. PubMed ID: 19564691
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Establishment of dihydrofolate reductase-increased human cell lines and relationship between dihydrofolate reductase levels and gene copy.
    Domin BA; Grill SP; Cheng Y
    Cancer Res; 1983 May; 43(5):2155-8. PubMed ID: 6831441
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Overproduction of two antigenically distinct forms of dihydrofolate reductase in a highly methotrexate-resistant mouse leukemia cell line.
    Dedhar S; Goldie JH
    Cancer Res; 1983 Oct; 43(10):4863-71. PubMed ID: 6192911
    [No Abstract]   [Full Text] [Related]  

  • 31. Role of methotrexate polyglutamylation and cellular energy metabolism in inhibition of methotrexate binding to dihydrofolate reductase by 5-formyltetrahydrofolate in Ehrlich ascites tumor cells in vitro.
    Matherly LH; Fry DW; Goldman ID
    Cancer Res; 1983 Jun; 43(6):2694-9. PubMed ID: 6189586
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cloning, expression, and characterization of Mycobacterium tuberculosis dihydrofolate reductase.
    White EL; Ross LJ; Cunningham A; Escuyer V
    FEMS Microbiol Lett; 2004 Mar; 232(1):101-5. PubMed ID: 15019741
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Variation of dihydrofolate reductase activity during in vitro and in vivo growth of sublines of L1210 lymphoma.
    Hillcoat BL
    J Natl Cancer Inst; 1971 Jan; 46(1):75-80. PubMed ID: 5546195
    [No Abstract]   [Full Text] [Related]  

  • 34. The crystal structure of dihydrofolate reductase from Thermotoga maritima: molecular features of thermostability.
    Dams T; Auerbach G; Bader G; Jacob U; Ploom T; Huber R; Jaenicke R
    J Mol Biol; 2000 Mar; 297(3):659-72. PubMed ID: 10731419
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Occurrence and significance of D-methotrexate as a contaminant of commercial methotrexate.
    Cramer SM; Schornagel JH; Kalghatgi KK; Bertino JR; Horváth C
    Cancer Res; 1984 May; 44(5):1843-6. PubMed ID: 6713386
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The structure of mouse L1210 dihydrofolate reductase-drug complexes and the construction of a model of human enzyme.
    Stammers DK; Champness JN; Beddell CR; Dann JG; Eliopoulos E; Geddes AJ; Ogg D; North AC
    FEBS Lett; 1987 Jun; 218(1):178-84. PubMed ID: 3595861
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Substrate and inhibitor complexes of dihydrofolate reductase from amethopterin-resistant L1210 cells.
    Neef VG; Huennekens FM
    Arch Biochem Biophys; 1975 Dec; 171(2):435-43. PubMed ID: 959
    [No Abstract]   [Full Text] [Related]  

  • 38. Age-dependent expression of a novel protein in mouse liver immunologically and functionally homologous with dihydrofolate reductase.
    Kyner D; Rothenberg SP
    Biochim Biophys Acta; 1989 Oct; 993(1):56-62. PubMed ID: 2804123
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Methotrexate. I. Pharmacology and pharmacokinetics.
    Lippens RJ
    Am J Pediatr Hematol Oncol; 1984; 6(4):379-95. PubMed ID: 6398629
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Dialkyl esters of methotrexate and 3',5'-dichloromethotrexate: synthesis and interaction with aldehyde oxidase and dihydrofolate reductase.
    Johns DG; Farquhar D; Wolpert MK; Chabner BA; Loo TL
    Drug Metab Dispos; 1973; 1(3):580-9. PubMed ID: 4149453
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.